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Abstract The essential amino acid tryptophan is the
precursor of the neurotransmitter serotonin. By depleting
the body of tryptophan, brain tryptophan and serotonin
levels are temporarily reduced. In this paper, several
experiments are described in which dose and treatment
effects of acute tryptophan depletion (ATD) using a gela-
tin-based protein–carbohydrate mixture were studied in
male and female Wistar rats. Two or three doses of tryp-
tophan depleting mixture resulted in 65–70% depletion
after 2–4 h in males. ATD effects were similar in females,
although females may return to baseline levels faster.
Treatment effects after four consecutive days of ATD were
similar to the effects of 1 day of treatment. Object recog-
nition memory was impaired 2, 4, and 6 h after the ﬁrst of
two doses of ATD, suggesting that the central effects
occurred rapidly and continued at least 6 h, in spite of
decreasing treatment effects on plasma tryptophan levels at
that time point. The method of acute tryptophan depletion
described here can be used to study the relationship
between serotonin and behaviour in both male and female
rats.
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Introduction
The neurotransmitter serotonin (5-hydroxytryptamine,
5-HT) plays a prominent role in various aspects of
behaviour and is known to be involved in numerous psy-
chiatric diseases (Maes and Meltzer 1995). Serotonin is
synthesised from its amino acid precursor tryptophan
(TRP), which is taken up from the blood. The level of TRP
in plasma depends on the balance between the dietary
intake of TRP and its removal from the plasma by protein
synthesis and enzymatic degradation. Most of the TRP in
plasma is protein-bound, with only 5% available for
transport into the CNS. Free TRP is transported into the
brain across the blood–brain barrier by an active protein
shuttle for which ﬁve other large neutral amino acids
(LNAAs: valine, leucine, isoleucine, phenylalanine, tyro-
sine) also compete. The ratio of TRP and these other
LNAAs (TRP/RLNAA ratio) is thought to be a more sen-
sitive index of brain tryptophan availability (Fernstrom
1981; Wurtman et al. 1980), because it is this ratio that
determines how much tryptophan can enter the brain. Once
in the brain, TRP is converted into 5-HT by a two-step
process catalysed by the enzymes tryptophan hydroxylase
and aromatic amino acid decarboxylase.
Tryptophan hydroxylase is not fully saturated at nor-
mal brain TRP levels, hence the availability of TRP is
the limiting factor in the synthesis of 5-HT. Because of
this, factors that inﬂuence brain TRP levels can inﬂuence
the rate of 5-HT synthesis. In the method of acute
tryptophan depletion (ATD) brain 5-HT is lowered by
depleting the body of TRP. Subjects ingest an amino
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contain TRP, but does contain high levels of the other
amino acids, resulting in a lowering of plasma TRP and
the TRP/RLNAA ratio, thus restricting the entry of TRP
into the brain. Due to its reversible and non-intrusive
effects, the method of ATD can be used in animals and
humans.
ATD lowers plasma TRP (Young et al. 1985) for
several hours via increased competition for transport
across the blood–brain barrier (Fernstrom 1981) and
increased protein synthesis in the liver (Moja et al. 1991).
Brain 5-HT levels are temporarily lowered (Biggio et al.
1974; Moja et al. 1989) and there is a decrease in brain
5-HT synthesis (Nishizawa et al. 1997) and concentrations
of 5-HT (Bel and Artigas 1996) and its metabolite
5-hydroxyindolacetic acid (5-HIAA) (Carpenter et al.
1998; Stancampiano et al. 1997; Williams et al. 1999).
The ATD method has been shown to affect various
aspects of behaviour (Booij et al. 2003; Moore et al. 2000;
Reilly et al. 1997). Impaired memory performance after
ATD has been shown consistently in human (Park et al.
1994; Riedel et al. 1999) and animal studies (Lieben et al.
2004b).
Sex may affect several outcome measures of ATD.
(Nishizawa et al. 1997) studied the effects of ATD on 5-HT
synthesis and found that the rates of 5-HT synthesis were
reduced by ATD by a factor of about 9.5 in men and a
factor of about 40 in women. Apparently, the effect of
ATD on 5-HT synthesis is larger in women than in men.
Several previous ATD studies in which gender effects were
considered showed that mood effects are larger in females
than in males (Booij et al. 2002; Ellenbogen et al. 1996;
Smith et al. 1997). In a mega-analysis, Sambeth et al.
(2007) found that the effects of ATD on verbal memory
were larger in women than in men on both the immediate
and delayed recall scores, despite similar levels of deple-
tion in males and females.
Previous studies in our lab have shown that ATD in
male rats results in a temporary lowering of plasma TRP
levels and TRP, 5-HT and 5-HIAA levels in several brain
regions (Lieben et al. 2004a). In females, a temporary
lowering of plasma TRP has been reported that was inde-
pendent of the female estrous cycle phase, whereas
depletion of brain TRP was stronger in females in pro-
estrus and estrus compared to females in met-estrus and
di-estrus (Jans et al. 2007a). Furthermore, reliable effects
of ATD on memory 4 h after treatment have been found in
male (Jans et al. 2007a; Lieben et al. 2004b) and female
rats (Jans et al. 2007a). In this paper, we describe several
experiments that were done to further characterise the
pharmacokinetic effects of ATD, using a gelatin-based
mixture, in male and female rats.
Material and methods
Experiments
A total of four experiments are described in this paper. In
experiment 1, time and TRP-time and dose effects were
studied in male rats. In experiment 2, time and dose effects
of acute TRP depletion and suppletion in females were
studied in female rats. In experiment 3, the effects of
repeated ATD were studied in female rats. In experiment 4
the effects of ATD on object recognition in males are
measured 2, 4 and 6 h after treatment.
Animals
In all experiments, subjects were 4-month-old Wistar rats,
male or female (Charles River, The Netherlands). In
experiment 2, 3, and 4 the rats were housed individually,
while in experiment 1 they were housed per two. In all
experiments, the rats were housed in standard Macrolon
cages on sawdust bedding in an air-conditioned room
(±21C). The animals had free access to food and water.
They were kept under a reversed 12/12-h light/dark cycle.
The lights were on from 0600 to 1800 hours. A radio,
which was playing softly, provided background noise. All
experimental procedures were approved by the local ethical
committee of the Maastricht University for animal exper-
iments and met governmental guidelines.
Materials
The Gelatin hydrolysate (Solugel
; Solugel C in experi-
ment 1 and Solugel P in experiments 2, 3, and 4) was
obtained from PB Gelatins (Tessenderlo, Belgium).
Glucodry 210 was obtained from the Amylumgroup (Koog
aan de Zaan, The Netherlands). L-tryptophan was obtained
from Sigma (Zwijndrecht, The Netherlands). Kaliumchlo-
ride (KCl), calciumchloride-dihydrate (CaCl22H2O) and
5-sulfosalicylic acid dihydrate were purchased from Merck
(Darmstadt, Germany).
Treatment
During a period of 2 weeks preceding the experiment, the
rats were handled and habituated to oral injections with
normal tap water (up to 10 ml/kg). On experimental days,
the rats were fasted 14 h prior treatment until the testing
period was completed. This was done to minimise the
availability of TRP from food which would counteract the
effects of the acute treatment. The rats were orally treated
with a protein–carbohydrate mixture containing TRP
(TRP+ group, 0.28% TRP of the total protein) or one
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The composition of the nutritional mixture (with Solugel P)
is shown in Table 1. In all experiments, one dose contained
4.0 g Solugel C/kg and 2.0 g Glucodry/kg of the body
weight and was given in a volume of 10 ml/kg between
0830 and 1230 hours. Blood samples were taken at base-
line (10 or 20 min before treatment) and at several time
points after treatment. Speciﬁc treatment conditions and
mean TRP values of each experiment are shown in Table 2.
Biochemistry
For the determination of plasma amino acid levels blood
samples were taken at resting values and repeated at several
points in time. Blood sampling was done via a tail-incision
method (Fluttert et al. 2000). Promptly after collection of
blood in a sodium heparin tubes (Microvette
 CB 300,
Sarstedt, Germany), the samples were kept on ice. After
centrifugation of the blood samples (at 4C for 15 min at
3,000g in a Hettich EBA 12 centrifuge), plasma was de-
proteinised with cups containing dry 5-sulfosalicylic acid
(6 mg/100 ll plasma) and the protein was spun down.
Samples were frozen in liquid nitrogen and stored at
-80C. Before analysis, samples were thawed at 4C,
vortex-mixed vigorously and centrifuged at 50,000g in a
Hereaus Model Biofuge Stratos for 10 min at 4C. From the
clear supernatant 20 ll was mixed with 1,960 ll water and
20 ll norvaline and stored in the cooled (7C) sample
compartment until analysis. In addition tototalplasma TRP,
the concentrations of several other amino acids were
determined with a fully automated high-performance liquid
chromatography (HPLC) system after precolumn derivati-
zation with ophthaldialdehyde (OPA) (van Eijk et al. 1993).
OPA-AA derivates were quantiﬁed with ﬂuorescence
detection. The concentrations of the total plasma TRP and
other amino acids are expressed as lmol/l.
Behaviour
The object recognition test was performed to measure the
effects of acute tryptophan depletion on cognition and was
performed as described in detail elsewhere (Ennaceur and
Delacour 1988; Prickaerts et al. 2002). The apparatus
consisted of a circular arena, 83 cm in diameter. Half of the
40-cm-high wall was made of grey polyvinyl chloride, the
other half of transparent polyvinyl chloride. The light
intensity (20 Lux) was equal in the different parts of the
apparatus. We used four different sets of objects that could
not be displaced by a rat. Each object was available in
triplicate. The different objects were: (1) a cone consisted
of a grey polyvinyl chloride base (maximal diameter
18 cm) with collar on top made of brass (total height
16 cm), (2) a standard 1 l transparent glass bottle (diameter
10 cm, height 22 cm) ﬁlled with water, (3) a massive metal
cube (10 9 5 9 7.5 cm) with two holes (diameter 1.9 cm),
and (4) a massive aluminium cube with a tapering top
(13 9 8 9 8 cm).
In the week preceding testing, the animals were adapted
to the procedure, i.e., they were allowed to explore the
apparatus (without any objects) twice for 3 min. In the
following days, the rats were tested until a stable dis-
crimination performance was shown. A testing session
comprised two trials. The duration of each trial was 3 min.
Two objects were placed in a symmetrical position about
10 cm away from the grey wall. A rat was always placed in
the apparatus facing the wall at the middle of the front
(transparent) segment. During the ﬁrst trial the apparatus
contained two identical objects. After the ﬁrst exploration
period the rat was put back in its home cage. One hour later
the rat was put back in the apparatus for the second trial,
but now with dissimilar objects, a familiar one and a new
one. The duration of exploring each object in trial 1 and
trial 2 was recorded manually with a personal computer.
Exploration was deﬁned as directing the nose to the object
at a distance of no more than 2 cm and/or touching the
object with the nose. Sitting on the object was not con-
sidered as exploratory behaviour. In order to avoid the
Table 1 Composition of the protein–carbohydrate mixture
Protein (Solugel
) in 100 ml water 100 g
Alanine 8.4
Arginine 7.7
Aspartic acid/asparagine 4.5
Glutamic acid/glutamine 10.0
Glycine 23.3
Histidine 0.9
Hydroxylysine 1.5
Hydroxyproline 12.3
Isoleucine 1.2
Leucine 2.6
Lysine 3.3
Methionine 0.9
Phenylalanine 1.6
Proline 13.7
Serine 3.4
Threonine 1.9
Tryptophan 0.0
Tyrosine 0.6
Valine 2.2
Carbohydrate (Glucodry 210) in 80 ml water 50
KCL 0.094
CaCl22H2O 2.32
L-tryptophan (TRP- group) 0
L-tryptophan (TRP + group) 0.28
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123presence of olfactory trails, the objects were always thor-
oughly cleaned. Moreover, each object was available in
triplicate so that none of the two objects from the ﬁrst trial
had to be used as the familiar object in the second trial. In
addition, all combinations and locations of objects were
used in a balanced manner to reduce potential biases due to
preferences for particular locations or objects. After the rats
were familiarised to the procedures of the task and had
stable baseline d2 values, testing with treatment began.
Results
Biochemistry
The mean concentrations of plasma amino acids were
determined for each treatment and time condition sepa-
rately. The extent of reduction (expressed in absolute
values and in percentage decline from resting values) was
calculated for total plasma TRP concentrations and for the
TRP/RLNAA ratio in experiments 1, 2, and 3. Extreme
values were excluded from statistical analysis. Differences
in plasma amino acid concentrations were analysed with
Generalised Linear Models (GLM), with main factor
‘treatment’ and repeated measure factor ‘time’. When
appropriate, post hoc Bonferroni analyses were performed
to further characterise the effects of treatment. Differences
were regarded as statistically signiﬁcant if P\0.05. An
overview of the treatment effects on plasma TRP values of
all experiments is shown in Table 2.
Behaviour
The basic measures in the object recognition test were the
times spent by rats exploring an object during trial 1 and
trial 2. The discrimination index d2 [(exploration new
object in trial 2—exploration familiar object in trial 2)/total
exploration time during trial 2] was calculated for each
treatment condition (see Rutten et al. 2007). d2 is a relative
index of discrimination between new and familiar object,
because it corrects for total exploration time in trial 2 (see
S ¸ık et al. 2003). Effects of treatment, time, and interactions
were analysed with univariate ANOVA.
Experiment 1: time and TRP- dose effects in males
This experiment consisted of four treatment conditions,
with six male rats per group. The rats were treated either
with one dose of TRP- (1TRP-), three doses of TRP- with
60-min intervals (3TRP-), one dose of TRP+ or one dose
of saline. Blood samples were taken at baseline and again
2, 4, and 6 h after baseline blood samples.
Plasma TRP
There was a Time 9 Treatment interaction effect on TRP
levels [F(9,54) = 14.31, P\0.001]. TRP levels changed
over the 6 h [Time: F(3,54) = 27.07, P\0.001] and there
was a treatment effect on TRP levels [F(3,18) = 17.27,
P\0.001]. Post hoc analysis showed that TRP levels
were higher in the saline condition than in both TRP-
conditions. TRP levels in the TRP+ condition were higher
than in the 3TRP-condition. There was no signiﬁcant
difference between the two TRP- conditions, and between
the saline and TRP+ condition. Separate analyses for each
treatment condition indicated that there was a signiﬁcant
time effect on TRP levels in both TRP-conditions
[1TRP-:F(3,15) = 21.65, P\0.001; 3TRP-:F(3,9) = 22.11,
P\0.001), but not in the TRP+ and the saline condition
(see Table 2).
Table 2 Overview of the effects of different treatment- and test conditions on the absolute TRP values in the different experiments
Exp Treatment groups Time (min): total plasma tryptophan levels (lmol/l)
n Sex Treatment Time effect T0 T2 T4 T6
1 6 M TRP+ NS 112.69 (3.87) 118.75 (4.43) 120.97 (2.74) 113.28 (3.46)
6 M 1TRP- P\0.001 118.03 (5.24) 67.88
+++, 999 (6.75) 88.30
+++, 999 (7.60) 111.08 (6.44)
6 M 3TRP- P\0.001 125.91 (3.17) 52.75
+++, 999 (7.85) 49.03
+++, 999 (15.39) 69.51
+++, 999 (11.95)
6 M Saline NS 133.50 (4.77) 127.35 (6.28) 135.39 (6.34) 118.41 (4.43)
2 4 F TRP+ P\0.05 110.04 (4.78) 113.44 (5.83) 88.43 (3.51) 128.58 (9.61)
8 F TRP++ P\0.001 112.38 32.90
+++ 54.59
+++ 100.05
+
4 F TRP- P\0.001 105.16 (7.18) 217.28
+++(12.10) 135.34
+++ (6.28) 104.91 (8.33)
3 3 F TRP+ NS 117.35 (12.31) 106.21 (4.40) 100.11 (8.74)
7 F TRP- P\0.001 107.54 (3.95) 34.40
+++ (2.55) 38.54
+++(2.90)
Mean (SEM); Exp experiment, M male, F female, n number of animals per treatment group, NS not signiﬁcant
Treatment effect: difference from TRP+:
+ P\0.05;
+++ P\0.001; difference from saline:
999 P\0.001
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There was a Time 9 Treatment interaction effect on the
TRP/RLNAA ratio [F(9,45) = 21.51, P\0.001]. The
TRP/RLNAA ratio changed over the 6-h [Time:
F(3,45) = 37.31, P\0.001]. There was a treatment effect
on the TRP/RLNAA ratio [F(3,15) = 22.24, P\0.001],
post hoc analysis revealed that the 3TRP- condition was
different from all other treatment conditions. There were
no signiﬁcant differences between other treatment condi-
tions. Separate analyses for each treatment condition
showed that there was a signiﬁcant time effect on the
TRP/RLNAA ratio in both TRP- conditions and in
the saline condition [1TRP-: F(3,12) = 20.01, P\0.001;
3TRP-: F(3,9) = 54.74, P\0.001; Saline: F(3,12) = 6.12,
P\0.01], but not in the TRP+ condition. Treatment
effects on the TRP/RLNAA ratio are shown in Fig. 1.
Experiment 2: time and dose effects of acute TRP
depletion and suppletion in females
In this experiment, female rats were treated with TRP- on
1 day and with TRP+ or TRP++ on another day. They
received two doses with 90 min interval. The TRP++
mixture contained 2.8% TRP, which is ten times the
amount of TRP that is used for the normal balanced TRP+
mixture. Thus, the TRP++ condition results in TRP sup-
pletion. Blood samples were taken at baseline and 2, 4, and
6 h after the ﬁrst injection.
Plasma TRP
There was a Time 9 Treatment interaction effect on TRP
levels [F(6,27) = 37.21, P\0.001]. There was an effect
of time [F(3,27) = 8.61, P\0.001] and treatment
[F(2,9) = 126.02, P\0.001] on TRP levels. Post hoc
analysis revealed that the TRP levels in all treatment
groups were signiﬁcantly different (see Table 2). Separate
analyses for each treatment condition revealed that there
was a time effect on TRP levels in all treatment conditions
[TRP-: F(3,9) = 84.80, P\0.001; TRP+: F(3,9) = 6.60,
P\0.05; TRP++: F(3,9) = 27.94].
Plasma TRP/RLNAA ratio
There was a Time 9 Treatment interaction effect on the
TRP/RLNAA ratio [F(6,24) = 30.75, P\0.001]. There
was a time effect [F(3,24) = 15.37, P\0.001] and a
treatment effect [F(2,8) = 15,77, P\0.01] on the TRP/
RLNAA ratio. Post hoc analysis showed that the TRP/
RLNAA ratio in the TRP++ condition was signiﬁcantly
different from that in the TRP- and TRP+ condition, while
TRP- and TRP+ did not differ signiﬁcantly. Separate
analyses for each treatment condition revealed that there
was an effect of time on the TRP/RLNAA ratio in all
treatment conditions [TRP-: F(3,6) = 52.29, P\0.001;
TRP+: F(3,9) = 4.48, P\0.05; TRP++: F(3,9) = 40.43,
P\0.001]. Treatment effects on the TRP/RLNAA ratio
are shown in Fig. 2.
Experiment 3: effects of repeated treatment
Female rats were treated on four consecutive days with
TRP- ﬁrst and 1 week later on four consecutive days with
TRP+. The rats were daily injected with two doses
with 90 min interval. They had access to normal food in
the afternoon of each day. In the evening, food was taken
away again (14 h before treatment the next day). On the
Fig. 1 Experiment 1: time and TRP- dose effects in males. The
effects of treatment on the ratio plasma TRP/RLNAA (mean values
and SEM). Percentages indicate the difference from baseline levels in
the TRP- conditions
Fig. 2 Experiment 2: time and dose effects of acute TRP depletion
and suppletion in females. The effects of treatment on the ratio
plasma TRP/RLNAA (mean values and SEM). Percentages indicate
the difference from baseline levels in the TRP depletion and TRP
suppletion condition
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4 h after the ﬁrst injection.
After four consecutive days of administration of TRP- or
TRP+, with blood samples being taken on the fourth day,
Time 9 Treatment interaction effects were found on TRP
[F(2,14) = 35.54, P\0.001] and the TRP/RLNAA ratio
[F(2,12) = 23.78, P\0.001]. There was an effect of time
on TRP [F(2,14) = 77.39, P\0.001] and on the TRP/
RLNAA ratio [F(2,12) = 189.34, P\0.001]. The time
effect on the TRP/RLNAA was signiﬁcant for both treat-
ment condition [TRP+: F(2,4) = 14.68, P\0.05; TRP-:
F(2,8) = 565.03, P\0.001], but there was a time effect on
TRP only in the TRP- condition [F(2,10) = 222.55,
P\0.001]. There were treatment effects on TRP
[F(1,7) = 61.49, P\0.001] and the TRP/RLNAA ratio
[F(1,6) = 99.13, P\0.001]. Treatment effects on the TRP/
RLNAA ratio are shown in Fig. 3, effects on TRP are
shown in Table 2.
When comparing the TRP- after four consecutive treat-
ment days with the TRP- condition of 1 day administration
thatwas taken earlier in thesameanimals (experiment2),an
interaction effect was not found for TRP [Time 9 Treat-
ment:F(2,16) = 2.66,NS],butthisinteractionwassigniﬁcant
for the TRP/RLNAA ratio [F(2,12) = 14.80, P\0.001].
There was a time effect for TRP [F(2,16) = 279.22,
P\0.001] and the TRP/RLNAA ratio [F(2,12) = 304.23,
P\0.001]. Treatment effects were not found, neither for
TRP [F(1,8) = 0.29, NS] nor for the TRP/RLNAA ratio
[F(1,6) = 0.78, NS].
When comparing the TRP+ after four consecutive
treatment days with the TRP+ condition of 1 day admin-
istration that was taken earlier in the same animals
(experiment 2), an interaction effect was not found for TRP
[Time 9 Treatment: F(2,8) = 3.52, NS], but this interaction
was marginally signiﬁcant for the TRP/RLNAA ratio
[F(2,8) = 4.23, P = 0.056]. There was a time effect for
TRP [F(2,8) = 10.18, P\0.05] and the TRP/RLNAA ratio
[F(2,8) = 10.78, P\0.05]. Treatment effects were not
found, neither for TRP [F(1,4) = 0.1, NS] nor for the TRP/
RLNAA ratio [F(1,4) = 0.23, NS].
Experiment 4: effects of ATD on object recognition
memory
Male rats (n = 24) were repeatedly treated with TRP- and
TRP+ on different days. They received two doses with
90 min interval and were repeatedly tested in the object
recognition test. There was a 1-h interval between the two
trials of the test, trial 1 took place at 2, 4, or 6 h after the ﬁrst
treatment on different testing days. There was a treatment
effect on discrimination index d2 [F(1,137) = 88.73,
P\0.001], TRP- treated rats had a lower d2 than TRP+
treated rats (Fig. 4). There was no effect of Time or a
Time 9 Treatment interaction effect on d2. The treatment
effectwas signiﬁcantatalltimepoints[2 h:F(1,45) = 23.42,
P\0.001; 4 h: F(1,45) = 35.14, P\0.001; 6 h: F(1,45) =
30.42, P\0.001].
Discussion
Acute tryptophan depletion resulted in a transient lowering
of plasma TRP and the TRP/RLNAA ratio in males and
females. To the best of our knowledge, this is the ﬁrst study
to give a detailed description of the effects of different doses
of acute tryptophan depletion and suppletion in adult male
and female Wistar rats. The exact characteristics of the
depletion seemed to depend on the number of doses, or the
amount of the TRP- mixture, the rat received. It appeared
that the number of dosages the male rats received in
experiment 1 inﬂuenced both the duration of the depletion
and its intensity. After one dose of TRP- the TRP/RLNAA
Fig. 3 Experiment 3: effects of repeated treatment. Effects of
treatment on the ratio plasma TRP/RLNAA (mean values and
SEM). Percentages indicate difference from baseline levels
Fig. 4 Experiment 4: effects of ATD on object recognition memory.
Effects of treatment on discrimination index d2 (mean values and
SEM). Statistical signiﬁcance *** P\0.001 compared to TRP+
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123ratio was not signiﬁcantly different from that in the TRP+
and saline condition. Thus, one dose may not be sufﬁcient to
cause signiﬁcant depletion of the TRP/RLNAA ratio. As the
level of plasma TRP/RLNAA depletion is about 70% with
two and three doses, this level may represent the highest
level of depletion that can be achieved using the method of
acute tryptophan depletion. Three doses of TRP- did not
result in lower TRP levels, but in longer duration of the TRP
depletion, which is of course at least partly explained by the
fact that the rats received their TRP- injections staggered
over a longer period of time.
Two doses of ATD resulted in depletion of TRP and the
TRP/RLNAA ratio in both males and females. When the
effects of two doses TRP- are compared to a study in which
males were treated with two doses TRP- (Lieben et al.
2004b), females showed similar levels of depletion at 2 h,
but less depletion than males at 4 and 6 h. Although one
should be cautious when comparing different studies, a
recent study comparing ATD effects in males and females
directly also showed slightly stronger depletion in males
4 h after treatment with two doses (Jans et al. 2007a). It is
striking that at 6 h, the female TRP/RLNAA ratio was back
at baseline levels (experiment 2), while the male ratio still
showed a treatment effect, with 49% depletion (Lieben
et al. 2004b). TRP levels showed the same effect, with 11%
depletion they were almost back to baseline levels in
females at 6 h (experiment 2), but in males they were still
30% lower than baseline levels (Lieben et al. 2004b). It
might be possible that females have a faster metabolism
and reach peak depletion faster than males and also return
to baseline levels faster. It is also interesting to note that in
females the TRP/RLNAA ratio returned to baseline levels
faster than plasma TRP levels, whereas the opposite
occurred in males. In males, plasma TRP depletion was
less than depletion of the TRP/RLNAA ratio at 6 h after
the ﬁrst dose (Lieben et al. 2004b).
ATD resulted in signiﬁcant impairment of object rec-
ognition measured 2, 4, or 6 h after the ﬁrst of two ATD
doses. Previously, reliable memory effects have been found
4 h after the ﬁrst treatment with two doses in males (Lieben
et al. 2004b) and females (Jans et al. 2007a), despite
stronger depletion effects on TRP/RLNAA in males.
Experiment 4 of this study showed that already at 2 h there
is a signiﬁcant impairment of object recognition memory,
suggesting central depletion effects at this time point. This
experiment also showed that object recognition memory in
males is still impaired 6 h after ATD treatment, in spite of
decreasing treatment effects on plasma TRP levels at that
time point. It can be concluded that two doses of ATD
impaired object recognition memory and that this effect is
both rapid and long lasting.
From experiment 1 it may be concluded that TRP+
treatment is an appropriate control condition, because the
TRP/RLNAA ratio was stable over time in the TRP+
condition. The TRP+ condition has nutritional value
whereas saline does not. Therefore, in a saline condition
amino acid levels may drop over time as a result of lack of
food intake, as the animals are deprived of normal food for
14 h before treatment and during the treatment period. In
experiment 1 plasma TRP levels were stable over time in
both the TRP+ and the saline condition, suggesting treat-
ment may affect the other LNAAs. In females, experiment
2 of this study, a time effect was found in the TRP+
condition, plasma TRP and the TRP/RLNAA ratio dropped
a bit over 6 h, both were especially low at 4 h. These
effects, however, were not replicated in a later experiment
(Jans et al. 2007a), where TRP levels were stable over time
in the TRP+ condition in males and both groups of
females. The TRP/RLNAA ratio did decrease over time
(Jans et al. 2007a) again suggesting treatment effects on
other LNAAs.
It is important to note that the TRP+ control condition
of this protein–carbohydrate mixture does not result in an
increase in TRP levels, whereas this increase has been
reported in TRP+ rats when using an amino acid mixture
that is often used in human ATD studies (Blokland et al.
2004). Suppletion of TRP, as in the TRP++ condition in
experiment 2, caused a fast increase of both TRP levels and
the TRP/RLNAA ratio that is most pronounced 2 h after
the ﬁrst injection. Six hours after the ﬁrst injection, TRP
levels are back to baseline levels, while the TRP/RLNAA
ratio is at that time point still somewhat higher than
baseline levels.
It could be argued that repeated treatment with the TRP-
diet might affect the level of depletion (e.g. adaptation to
diet). However, we observed that repeated exposure to ATD
does not affect the depletion effects. When comparing TRP-
treatment on 1 day with treatment on four consecutive days,
there was no signiﬁcant difference in TRP levels or TRP/
RLNAA ratio. In the TRP+ condition the TRP/RLNAA
ratio decreased over time on the fourth day of treatment, but
there was no difference when comparing 1 day of TRP+
treatment with treatment on four consecutive days. The
effects of ATD are transient, TRP levels return to baseline
severalhoursaftertreatmentonthedaythattheratistreated,
even when the rats do not have access to food. When the rats
were treated on four consecutive days, baseline levels and
treatmenteffectsonthefourthdayweresimilartotheeffects
of 1-day treatment. This may be an important ﬁnding, as in
rat ATD studies a protocol with treatment on several con-
secutive days is not uncommon (Blokland et al. 2002;
Lieben et al. 2004b; Jans et al. 2007a).
Itshouldbenotedthatinexperiment1ofthepresentstudy
andapreviousstudy(Liebenetal.2004b)theproteinSolugel
Cwasused,whereasinexperiments2,3,and4ofthepresent
study and several other studies (Lieben et al. 2004a; Jans
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123etal.2007a)SolugelPwas usedin the protein–carbohydrate
mixture. The difference between these two products is that
they differ in sensory characteristics (i.e., smell and taste).
However, as there are no differences in composition,
molecular weight and length of the collagen hydrolysate
chains between Solugel P and C, this is unlikely to explain
differences in treatment effects in these experiments.
In conclusion, the method of ATD can be used to
temporarily lower peripheral tryptophan levels and conse-
quently affect 5-HT levels. A protocol with two injections
with90 minintervaloronewiththreeinjectionswith60 min
interval resulted in depletion of peripheral TRP levels of
about 65–70% 2–4 h after the ﬁrst treatment. Object recog-
nition was impaired 2, 4, and 6 h after the ﬁrst of two doses
ATD, suggesting that the central effects of ATD occurred
rapidly and continued until at least 6 h after the ﬁrst of two
doses,inspiteofdecreasingtreatmenteffectsonplasmaTRP
levelsatthattimepoint.Thenumberofdosestheratreceives
appears to mainly affect the duration of the depletion as the
doses are staggered over a longer period of time. Two doses
of TRP- appeared to result in comparable depletion of TRP
and TRP/RLNAA in males and females, although females
may return to baseline levels faster than males. Treatment
effects after 1 day of treatment were not different from
treatment effects after four consecutive days of treatment.
TRP+ treatment appeared to be an appropriate control
condition. This method of ATD can provide a useful tool to
study the effects of a transient lowering of 5-HT levels on
cognition and symptoms of depression and anxiety in both
humans and rats. ATD results in impaired memory, but
affects mood only in subjects that are vulnerable to develop
depression (Riedel et al. 1999; Riedel et al. 2002; Booij and
Van der Does 2007). By challenging the 5-HT system, ATD
can be used to assess the vulnerability of that system and the
roleitplaysinnormalandpathologicalbehaviour(Jansetal.
2007b).
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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